Case report: Multifocal chronic paracoccidioidomycosis in an adult
Paracoccidioidomycosis Paracoccidioides brasiliensis Diagnosis Amphotericin B Itraconazole Complications
Main Article Content
Paracoccidioides brasiliensis is the ethiological agent of one of the most prevalent systemic mycosis in Latin America, where around ten-million individuals are affected. Brazil has the highest incidence but in Venezuela, Colombia, Ecuador, and Argentina cases have also been reported. We describe a 56-year-old male with a one year history of lip, oral mucosa, and lung lesions. Granulomas and multinucleated giant cells were observed in histopathological evaluation with haematoxilyn-eosin stain. Mycologic studies (KOH and Gomori Grocott stain) showed blastoconidias with multiple budding. Serologic tests for paracoccidioidine were reactive. A diagnosis of chronic multifocal paracoccidioidomycosis was made. Initially, amphotericin B 0.7 mg/kg per day was started for fifteen days and consecutively itraconazole (400 mg/day) was administered orally with improvement of skin and lung lesions; however, an important residual fibrosis was observed. The patient was lost to follow up. We highlight the importance of an early diagnosis and adequate treatment to decrease sequelae in patient quality of life.
Zapata, K., Villanueva, J., Arrunátegui, A., & López, J. G. (2011). Case report: Multifocal chronic paracoccidioidomycosis in an adult. Colombia Medica, 42(2), 228–232. https://doi.org/10.25100/cm.v42i2.776
Download data is not yet available.
- Adriana Arrunátegui, In memoriam. , Colombia Medica: Vol. 30 No. 1 (1999)
- Luis Hernando Moreno, Adriana Arrunátegui, Treatment of gangrenous pioderma with rifampicine. , Colombia Medica: Vol. 39 No. 2 (2008)
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use